| Schedule of Segment Expenses Presented in CODM |
Segment expenses presented to the CODM were the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
(in thousands) |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Collaboration Revenue |
|
$ |
— |
|
|
$ |
35,000 |
|
|
$ |
— |
|
|
$ |
35,000 |
|
Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Belrestotug expense |
|
|
(34,034 |
) |
|
|
(11,871 |
) |
|
|
(40,464 |
) |
|
|
(24,452 |
) |
Inupadenant expense |
|
|
(2,190 |
) |
|
|
(5,813 |
) |
|
|
(3,545 |
) |
|
|
(11,329 |
) |
EOS-984 expense |
|
|
(2,985 |
) |
|
|
(3,170 |
) |
|
|
(6,182 |
) |
|
|
(5,351 |
) |
EOS-215 expense |
|
|
(3,661 |
) |
|
|
(3,594 |
) |
|
|
(5,909 |
) |
|
|
(6,252 |
) |
Other R&D activities expense |
|
|
(2,253 |
) |
|
|
(1,061 |
) |
|
|
(5,437 |
) |
|
|
(2,214 |
) |
R&D payroll |
|
|
(7,947 |
) |
|
|
(6,409 |
) |
|
|
(15,874 |
) |
|
|
(13,197 |
) |
R&D stock-based compensation |
|
|
(2,317 |
) |
|
|
(2,478 |
) |
|
|
(4,837 |
) |
|
|
(4,280 |
) |
G&A payroll |
|
|
(3,370 |
) |
|
|
(2,933 |
) |
|
|
(6,368 |
) |
|
|
(5,766 |
) |
G&A stock-based compensation |
|
|
(3,564 |
) |
|
|
(5,584 |
) |
|
|
(7,679 |
) |
|
|
(11,045 |
) |
General and overhead expense |
|
|
(5,184 |
) |
|
|
(5,997 |
) |
|
|
(11,191 |
) |
|
|
(12,309 |
) |
Restructuring costs |
|
|
(16,335 |
) |
|
|
|
|
|
(16,335 |
) |
|
|
|
Other segment items (1) |
|
|
5,619 |
|
|
|
6,833 |
|
|
|
11,028 |
|
|
|
15,851 |
|
Adjustments (2) |
|
|
(508 |
) |
|
|
(51 |
) |
|
|
(548 |
) |
|
|
— |
|
Consolidated net loss |
|
$ |
(78,729 |
) |
|
$ |
(7,128 |
) |
|
$ |
(113,341 |
) |
|
$ |
(45,344 |
) |
(1) Other segment items consists of interest income, grant income, research and development tax credit income, income tax benefit (expense) and other income items including foreign exchange gains and losses. (2) Adjustments include minor miscellaneous items excluded from the CODM package that need to be included in the presentation above in order to reconcile to consolidated net loss.
|